Effects of Lemborexant on insomnia in patients with schizophrenia : A randomized controlled study
Not Applicable
- Conditions
- Insomnia in patients with schizophrenia
- Registration Number
- JPRN-UMIN000049310
- Lead Sponsor
- Department of Psychiatry, Kurita Hospital, 695 Kurita Nagano-City Nagano, Japan, 380-0921
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
1.Coexisting with mood disorder, anxiety disorder, drug addiction, or personality disorder. 2.Suffering from serious physical diseases such as cerebrovascular disease, heart disease, renal dysfunction, and neurological disease. 3.Coexisting with other sleep disorders such as hypersomnia, sleep-related breathing disorders, circadian rhythm sleep disorders, parasomnia, and sleep-related movement disorders. 4.Actigraphy cannot be performed safely.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep variables obtained from actigraphs. Comparison between the 7-day pre-observation period and the 7th to 13th days after the intervention.
- Secondary Outcome Measures
Name Time Method Association between change from baseline in sleep variables obtained from Actigraphs and blood orexin A levels at night.